In a literature survey, Chernoff et al.(2017) dismissed the hypothesis that chronic exposure
to β-N-methylamino-L-alanine (BMAA) may be a risk factor for progressive …

Research interest in a non-protein amino acid β-N-methylamino-L-alanine (BMAA) arose
due to the discovery of a connection between exposure to BMAA and the occurrence of …

The neurotoxin β-N-methylamino-L-alanine (BMAA) is a natural non-proteinogenic diamino
acid produced by several species of both prokaryotic (cyanobacteria) and eukaryotic …

β-methylamino-L-alanine (BMAA) is a non-protein amino acid that has been implicated as a
risk factor for motor neurone disease (MND). BMAA is produced by a wide range of …

In the present review we have discussed the occurrence of β-N-methylamino-L-alanine
(BMAA) and its natural isomers, and the organisms and sample types in which the toxin (s) …

Cyanotoxins (CTs) are a large and diverse group of toxins produced by the peculiar
photosynthetic prokaryotes of the domain Cyanoprokaryota. Toxin‐producing aquatic …

The cytoprotective mechanism of l-serine against oxidative stress-mediated neuronal
apoptosis was investigated in mouse hippocampal neuronal HT22 cells. Treatment with the …

β-N-methylamino-l-alanine (BMAA) is a nonproteinogenic amino acid that has been
associated with neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) …

Cyanobacteria are photosynthetic microorganisms distributed globally in aquatic and
terrestrial environments. They are also industrially cultivated to be used as dietary …

Aims Brain disease, in its many forms, has recently demonstrated a great socio-economic
impact and represents one of the hardest challenges of present research. Although each …